Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 9 results for "pharma lifesciences sujay shetty"

Sun Pharma to pay $3.2 billion for Ranbaxy, will be world No. 5
Times of India

Sun Pharmaceutical may drop Ranbaxy brand from drugs in US; EM...

According to The Times of India, as well as sources close to the matter, Sun Pharmaceutical may phase out the Ranbaxy brand on generic drugs in the US after completing its $3.2-billion acquisition of the company. The people familiar with the ... FirstWord Pharma, 6 days ago
[x]  

Sun may let Ranbaxy brand die a slow death

MUMBAI: The Ranbaxy brand may be allowed to die a slow death over the next two to three years by the company's new owner - Sun Pharma - due to the negativity surrounding its product quality. Sun Pharma announced on Monday that it will buy the ...
 Times of India1 week ago RANBAXY LABORATORIES : Sun may let Ranbaxy brand die a slow death  4 Traders5 days ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less